title: Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly.
abstract: Studies about the impact of HDL-C levels on the incidence of cardiovascular disease (CVD) in the elderly are scarce. We decided to evaluate the relation of clinical and laboratory variables to the incidence of CVD events in the elderly stratified according to HDL-C behavior in an 8-year follow-up. We assessed 126 elderly (mean age: 70.01±7.24 years; 33.3% were men) on two occasions (assessment 1=A1, and assessment 2=A2), with a minimum of 5-year interval. They underwent clinical and laboratory evaluation and were divided into three groups as follows: (1) GN (n=52), normal HDL-C levels on A1 and A2; (2) GL (n=36), low HDL-C levels on A1 and A2; (3) GV (n=38), HDL-C levels varying from A1 to A2. The following CVD events were observed: coronary artery disease (angina pectoris=AP, myocardial infarction=MI, percutaneous/surgical coronary intervention); stroke; transient ischemic attack=TIA; carotid disease; and heart failure=HF. The groups did not differ in age or gender at A1 and A2. Triglyceride=TG mean levels were lower in GN at A1 (p=0.007) and A2 (p<0.001) than in GL. There were 14 CVD events in GN (26.9%), 23 (63.9%) in GL, and 13 (34.2%) in GV (χ2=12.825; p=0.002). In logistic regression analysis, we observed that the higher the systolic blood pressure (SBP) (odds ratio [OR]=1.0231; p=0.0338) and the lower the HDL-C (OR=0.9363; p=0.0035), the higher the incidence of CVD events. Persistently low HDL-C levels over 8 years of follow-up were a risk factor (RF) for the development of CVD events in the elderly.
authors.affiliation: Pedro Ernesto University-affiliated Hospital, Rio de Janeiro State University, Rua Almirante Benjamim Sodré 40/702, Laranjeiras, Rio de Janeiro, RJ, CEP 22240-080, Brazil. elizabet.rlk@terra.com.br
authors.forename: Elizabete Viana
authors.initials: EV
authors.lastname: de Freitas
authors.forename: Andréa Araújo
authors.initials: AA
authors.lastname: Brandão
authors.forename: Roberto
authors.initials: R
authors.lastname: Pozzan
authors.forename: Maria Eliane
authors.initials: ME
authors.lastname: Magalhães
authors.forename: Flávia
authors.initials: F
authors.lastname: Fonseca
authors.forename: Oswaldo
authors.initials: O
authors.lastname: Pizzi
authors.forename: Erika
authors.initials: E
authors.lastname: Campana
authors.forename: Ayrton Pires
authors.initials: AP
authors.lastname: Brandão
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000502:physiology*; D001938:Brazil / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000097:blood* / Q000453:epidemiology* / Q000209:etiology; D008076:Cholesterol, HDL / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D016015:Logistic Models; D008297:Male; D012307:Risk Factors; D012959:Socioeconomic Factors
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL